$295.00
GLP-2 Microdosed (Tirzepatide) is a synthetic dual agonist peptide studied for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors involved in metabolic signaling pathways. By engaging these receptor systems, Tirzepatide is utilized in experimental models examining coordinated incretin signaling, receptor binding kinetics, and intracellular pathway activation. Preclinical research employs Tirzepatide to investigate glucose metabolism mechanisms, peptide stability, and integrated endocrine regulation within controlled laboratory environments.
For research use only. Not for human consumption.
References:
Frias JP et al., The Lancet, 2018
Jastreboff AM et al., New England Journal of Medicine, 2022
Müller TD et al., Nature Reviews Drug Discovery, 2022
GLP-2 Microdosed (Tirzepatide) is a synthetic dual receptor agonist peptide developed for laboratory research involving incretin and metabolic signaling pathways. It is designed to interact with GLP-1 and GIP receptors in experimental research models.
Biochemical Characteristics
Tirzepatide is a large synthetic peptide engineered to activate both GLP-1 and GIP receptor systems. Its structure supports receptor affinity and stability suitable for controlled biochemical and pharmacological research applications.
Research Applications
Tirzepatide is utilized in laboratory studies examining incretin receptor signaling, metabolic pathway modulation, peptide–receptor binding dynamics, and endocrine feedback mechanisms.
Pathway / Mechanistic Context
Mechanistic research focuses on GLP-1 and GIP receptor activation and downstream intracellular signaling cascades influencing metabolic regulation and hormone signaling pathways under experimental conditions.
Preclinical Research Summary
Preclinical investigations have evaluated Tirzepatide in in vitro and experimental models to study receptor activation, metabolic pathway integration, and endocrine signaling coordination.
Form & Analytical Testing
GLP-2 Microdosed (Tirzepatide) is supplied as a lyophilized peptide and undergoes analytical verification, including HPLC testing, to confirm purity and composition consistency.
RUO Disclaimer
This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.
Reviews
There are no reviews yet.